http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019089739-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_81ab7ff4bc463bbc54ebcb1b961d36ec |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-409 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-00 |
| filingDate | 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec4b4f4d6dea0221847567d773ee5d2c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c974201ab9222296af36d7565820b776 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dae6be658732469d6e4eef819ba63158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_76ee8275a3377104654990f9bc30fb8a |
| publicationDate | 2019-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019089739-A |
| titleOfInvention | Ryanodine receptor activator and use thereof |
| abstract | The present invention provides ryanodine receptor activators and uses thereof. The present invention relates to an activator of ryanodine receptor expressed in nerve cells, which comprises carbon monoxide, carbon monoxide donor, carbon monoxide production inducer and carbon monoxide metabolism inhibitor. The present invention provides a ryanodine receptor activator, and its use, comprising as an active ingredient a substance selected from the group consisting of The present invention is also directed to a treatment for ryanodine receptor related diseases, which comprises as an active ingredient a substance selected from the group consisting of carbon monoxide, carbon monoxide donors, carbon monoxide production inducers and carbon monoxide metabolism inhibitors. The present invention also provides a medicament for treating ryanodine receptor related diseases or a medicament for treating monoamine related diseases, and a use thereof, which comprises the medicament or the medicament for treating monoamine related diseases and the carbon monoxide production inhibitor as a medicinal ingredient. [Selected figure] Figure 9 |
| priorityDate | 2017-11-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 242.